WebinarsNew
Deep DiveNew
Explore Business Standard
The revenue stands at ₹9,150.35 crore, reflecting a quarter-on-quarter *(QoQ) increase of 3.35 per cent from ₹8,853.34 crore. This corresponds to a year-on-year *(YoY) growth of 16.30 per cent.
Operating Profit stands at ₹1,839.34 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.08 per cent from ₹1,750.35 crore. This corresponds to a year-on-year *(YoY) growth of 14.74 per cent.
PBDT stands at ₹2,001.91 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.15 per cent from ₹1,769.18 crore. This corresponds to a year-on-year *(YoY) growth of 24.15 per cent.
Profit Before Tax stands at ₹1,515.09 crore, reflecting a quarter-on-quarter *(QoQ) increase of 17.39 per cent from ₹1,290.61 crore. This corresponds to a year-on-year *(YoY) growth of 25.55 per cent.
Net Profit stands at ₹1,032.03 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.07 per cent from ₹920.84 crore. This represents a 25.22 per cent year-on-year *(YoY) growth for the same year.
| Category | Q1 FY26-27 | Q1 FY25-26 | Change % | FY25-26 | FY24-25 | Change % |
|---|---|---|---|---|---|---|
| Total Revenue | 9,150.35 | 7,868.14 | 16.30 | 33,653.08 | 31,723.73 | 6.08 |
| Expenses | 7,311.01 | 6,265.11 | 16.69 | 26,872.68 | 25,172.63 | 6.75 |
| Other Income | 264.23 | 107.22 | 146.44 | 493.61 | 621.85 | -20.62 |
| Operating Profit | 1,839.34 | 1,603.03 | 14.74 | 7,274.01 | 7,172.95 | 1.41 |
| Depreciation | 486.82 | 405.70 | 20.00 | 1,778.19 | 1,649.42 | 7.81 |
| Interest | 101.66 | 97.75 | 4.00 | 383.97 | 457.24 | -16.02 |
| Profit Before Tax | 1,515.09 | 1,206.80 | 25.55 | 5,111.85 | 5,066.29 | 0.90 |
| Tax | 483.06 | 382.60 | 26.26 | 1,736.14 | 1,699.98 | 2.13 |
| Net Profit | 1,032.03 | 824.20 | 25.22 | 3,502.97 | 3,483.57 | 0.56 |
| Category | Q1 FY26-27 | Q1 FY25-26 | Change % | FY25-26 | FY24-25 | Change % |
|---|---|---|---|---|---|---|
| Total Revenue | 2,799.51 | 2,848.17 | -1.71 | 11,171.72 | 10,933.30 | 2.18 |
| Expenses | 1,917.26 | 2,051.83 | -6.56 | 8,097.16 | 8,375.73 | -3.33 |
| Other Income | 241.89 | 83.77 | 188.75 | 587.53 | 328.12 | 79.06 |
| Operating Profit | 2,660.89 | 2,555.95 | 4.11 | 3,662.09 | 2,885.69 | 26.91 |
| Depreciation | 68.99 | 70.02 | -1.47 | 285.36 | 297.20 | -3.98 |
| Interest | 47.07 | 60.00 | -21.55 | 213.15 | 230.04 | -7.34 |
| Profit Before Tax | 1,008.08 | 750.09 | 34.39 | 3,163.58 | 2,358.45 | 34.14 |
| Tax | 270.86 | 190.96 | 41.84 | 746.82 | 627.37 | 19.04 |
| Net Profit | 737.22 | 559.13 | 31.85 | 2,414.80 | 1,746.79 | 38.24 |
| Category | Q1 FY26-27 | Q4 FY25-26 | Change % |
|---|---|---|---|
| Total Revenue | 9,150.35 | 8,853.34 | 3.35 |
| Expenses | 7,311.01 | 7,102.99 | 2.93 |
| Other Income | 264.23 | 117.04 | 125.76 |
| Operating Profit | 1,839.34 | 1,750.35 | 5.08 |
| Depreciation | 486.82 | 478.57 | 1.72 |
| Interest | 101.66 | 98.21 | 3.51 |
| Profit Before Tax | 1,515.09 | 1,290.61 | 17.39 |
| Tax | 483.06 | 369.77 | 30.64 |
| Net Profit | 1,032.03 | 920.84 | 12.07 |
| Category | Q1 FY26-27 | Q4 FY25-26 | Change % |
|---|---|---|---|
| Total Revenue | 2,799.51 | 2,786.55 | 0.47 |
| Expenses | 1,917.26 | 2,005.13 | -4.38 |
| Other Income | 241.89 | 214.09 | 12.99 |
| Operating Profit | 2,660.89 | 2,599.19 | 2.37 |
| Depreciation | 68.99 | 71.93 | -4.09 |
| Interest | 47.07 | 47.27 | -0.42 |
| Profit Before Tax | 1,008.08 | 876.31 | 15.04 |
| Tax | 270.86 | 184.08 | 47.14 |
| Net Profit | 737.22 | 692.23 | 6.50 |
Data not available.
| Company | 1 Day | 1 Week | 1 Month | 3 Months | 6 Month | 1 Year |
|---|---|---|---|---|---|---|
| Aurobindo Pharma | 4.50% | 4.40% | 6.16% | 11.78% | 47.99% | 57.77% |
| Mankind Pharma | 0.33% | -1.43% | -3.40% | -1.23% | 17.71% | 0.10% |
| Laurus Labs | 1.03% | 2.43% | 20.59% | 46.46% | 92.10% | 123.14% |
| Dr Reddy's Labs | -0.26% | 0.18% | -5.90% | -8.42% | -6.67% | -3.87% |
| Biocon | -1.71% | 1.65% | 2.76% | 10.12% | 15.93% | 25.71% |
| Alkem Lab | 0.38% | -0.92% | -0.69% | 0.57% | -3.15% | 16.28% |
| Glenmark Pharma. | -0.52% | 4.98% | 0.21% | -2.69% | 16.90% | 11.67% |